These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35893692)

  • 21. Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA).
    Chiam R; Sharp E; Maan S; Rao S; Mertens P; Blacklaws B; Davis-Poynter N; Wood J; Castillo-Olivares J
    PLoS One; 2009 Jun; 4(6):e5997. PubMed ID: 19543394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness.
    Rutkowska DA; Mokoena NB; Tsekoa TL; Dibakwane VS; O'Kennedy MM
    BMC Vet Res; 2019 Dec; 15(1):432. PubMed ID: 31796116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The complete sequence of four major structural proteins of African horse sickness virus serotype 6: evolutionary relationships within and between the orbiviruses.
    Williams CF; Inoue T; Lucus AM; Zanotto PM; Roy P
    Virus Res; 1998 Jan; 53(1):53-73. PubMed ID: 9617769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. African horse sickness outbreaks caused by multiple virus types in Ethiopia.
    Aklilu N; Batten C; Gelaye E; Jenberie S; Ayelet G; Wilson A; Belay A; Asfaw Y; Oura C; Maan S; Bachanek-Bankowska K; Mertens PP
    Transbound Emerg Dis; 2014 Apr; 61(2):185-92. PubMed ID: 23083078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
    van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
    J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of African horse sickness virus VP7 antigen, synthesised in bacteria, and anti-VP7 monoclonal antibodies in a competitive ELISA.
    Wade-Evans AM; Woolhouse T; O'Hara R; Hamblin C
    J Virol Methods; 1993 Dec; 45(2):179-88. PubMed ID: 8113344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and optimisation of a duplex real-time reverse transcription quantitative PCR assay targeting the VP7 and NS2 genes of African horse sickness virus.
    Quan M; Lourens CW; MacLachlan NJ; Gardner IA; Guthrie AJ
    J Virol Methods; 2010 Jul; 167(1):45-52. PubMed ID: 20304015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform.
    van Rijn PA; Maris-Veldhuis MA; Potgieter CA; van Gennip RGP
    Vaccine; 2018 Apr; 36(15):1925-1933. PubMed ID: 29525278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the major core antigen VP7 of African horsesickness virus by a recombinant baculovirus and its use as a group-specific diagnostic reagent.
    Chuma T; Le Blois H; Sánchez-Vizcaíno JM; Diaz-Laviada M; Roy P
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():925-31. PubMed ID: 1378881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural insight into African horsesickness virus infection.
    Manole V; Laurinmäki P; Van Wyngaardt W; Potgieter CA; Wright IM; Venter GJ; van Dijk AA; Sewell BT; Butcher SJ
    J Virol; 2012 Aug; 86(15):7858-66. PubMed ID: 22593166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The complete sequence of the group-specific antigen, VP7, of African horsesickness disease virus serotype 4 reveals a close relationship to bluetongue virus.
    Roy P; Hirasawa T; Fernandez M; Blinov VM; Sanchez-Vixcain Rodrique JM
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1237-41. PubMed ID: 1646273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolutionary relationships among the gnat-transmitted orbiviruses that cause African horse sickness, bluetongue, and epizootic hemorrhagic disease as evidenced by their capsid protein sequences.
    Iwata H; Yamagawa M; Roy P
    Virology; 1992 Nov; 191(1):251-61. PubMed ID: 1329319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of competitive ELISA for serodiagnosis on African horsesickness virus using baculovirus expressed VP7 and monoclonal antibody.
    Kweon CH; Kwon BJ; Ko YJ; Kenichi S
    J Virol Methods; 2003 Oct; 113(1):13-8. PubMed ID: 14500122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification and properties of virus particles, infectious subviral particles, cores and VP7 crystals of African horsesickness virus serotype 9.
    Burroughs JN; O'Hara RS; Smale CJ; Hamblin C; Walton A; Armstrong R; Mertens PP
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():1849-57. PubMed ID: 8046387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of domain-switching and site-directed mutagenesis on the properties and functions of the VP7 proteins of two orbiviruses.
    Monastyrskaya K; Staeuber N; Sutton G; Roy P
    Virology; 1997 Oct; 237(2):217-27. PubMed ID: 9356334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Requirements and comparative analysis of reverse genetics for bluetongue virus (BTV) and African horse sickness virus (AHSV).
    van Rijn PA; van de Water SG; Feenstra F; van Gennip RG
    Virol J; 2016 Jul; 13():119. PubMed ID: 27368544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preparation and identification of monoclonal antibodies against African horse sickness virus VP7].
    DU F; Feng C; Wang C; Qiu S; Zhang Y; Lin X; Wu S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Dec; 34(12):1125-1129. PubMed ID: 30626480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural studies of orbivirus particles.
    Stuart DI; Gouet P; Grimes J; Malby R; Diprose J; Zientara S; Burroughs JN; Mertens PP
    Arch Virol Suppl; 1998; 14():235-50. PubMed ID: 9785510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective immunity of plant-produced African horse sickness virus serotype 5 chimaeric virus-like particles (VLPs) and viral protein 2 (VP2) vaccines in IFNAR
    O'Kennedy MM; Coetzee P; Koekemoer O; du Plessis L; Lourens CW; Kwezi L; du Preez I; Mamputha S; Mokoena NB; Rutkowska DA; Verschoor JA; Lemmer Y
    Vaccine; 2022 Aug; 40(35):5160-5169. PubMed ID: 35902279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reverse genetics approaches: a novel strategy for African horse sickness virus vaccine design.
    Calvo-Pinilla E; Marín-López A; Utrilla-Trigo S; Jiménez-Cabello L; Ortego J
    Curr Opin Virol; 2020 Oct; 44():49-56. PubMed ID: 32659516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.